San Antonio Business Journal (October 12, 2015) BioAffinity Technologies Inc., a development-stage biotech company launched in San Antonio in March 2014, has found solid footing in South Texas.
read moreSAN ANTONIO, TX (October 7, 2015) bioAffinity Technologies, a privately held cancer diagnostics company, will seat two new members on its Board of Directors at the third-quarter meeting Oct. 26, 2015.
read moreSAN ANTONIO, TX (October 4, 2015) Early detection of cancer prolongs life. Each of us at bioAffinity Technologies has seen this firsthand. Our brothers, sisters, parents, friends and patients, and many of us personally, have benefited from early cancer detection.
read moreSAN ANTONIO, TX (September 30, 2015) bioAffinity Technologies, a privately held cancer diagnostics company, today announced the renewal of its research collaboration with The University of Texas Health Science Center at San Antonio.
read moreSAN ANTONIO, TX (September 23, 2015) bioAffinity Technologies, a privately held cancer diagnostics company, today announced that results from a 128-patient proof-of-concept clinical study for its non-invasive and quantitative assay for early-stage lung cancer were published in the Journal of Thoracic Oncology.
read more
bioAffinity Technologies was selected as one of San Antonio’s Top 2020 Innovators. In this video, you will see Maria Zannes, President and Chief Executive Officer, speak about what drives motivation, innovation and success and kick off San Antonio’s premier annual event celebrating the City’s healthcare and bioscience industry.